Veteran IP litigator Hiroshi Sheraton and M&A lawyer Luciana Griebel join in London | 1yr
Life Sciences - Page 5
The way the request was processed still raises ‘significant concerns’, says the firm | 1yr
Nickolas Bogdanovich joins after Cleary M&A partner James Langston defected to Paul Weiss in May | 1yr
Firm hires from Goodwin for fifth California office | 1yr
This comparative guide offers a practical overview of the enforcement of judgments and arbitration awards across multiple jurisdictions. | 2mos
Alexander Klett, Christoph Mikyska and Sebastian Dexheimer move over from Reed Smith and Milbank | 1yr
PEP rises 7% to £1,076k after flatlining in FY23 | 1yr
Pan-European patent court delivers first revocation judgment a year and a month after opening | 1yr
Trio of partners join from Wilson Sonsini and boutique Hooper Lundy & Bookman as Orrick continues life sciences push | 1yr
Raleigh office will target healthcare work and is top 50 firm’s 23rd US base | 2yrs
Glucose monitoring patent revoked across 17 UPC member states in ongoing dispute with rival Abbott | 2yrs
Freshfields, Taylor Wessing and Powell Gilbert advise on closely watched London High Court dispute | 2yrs
IP and disputes group’s move follows ArentFox Schiff adding automotive partner quartet from Burns in Boston in April | 2yrs
Team moves over from Lerner David strengthening medical device practice | 2yrs
Decision upholds earlier ruling revoking patent covering the drug Xarelto, further clearing way for generic manufacturers to enter the lucrative market | 2yrs
Tobias Knapp joins as co-head of global firm’s New York transactional group | 2yrs
Covington counsels Biogen as Goodwin reps acquisition target Human Immunobiology Biosciences | 2yrs
Former FDA lawyers Jennifer Bragg and William McConagha move over in DC as Safehold CLO Douglas Heitner joins real estate team in New York | 2yrs
Office to handle outbound work for Japanese clients as UK firm aims to reach €1bn revenue in five years | 2yrs
Led by respected life sciences litigator Siegmund Gutman, the team of 10 move over from Proskauer Rose | 2yrs
Düsseldorf local division orders US life sciences company Curio Bioscience to stop selling its products in Germany, France and Sweden in dispute with rival 10x Genomics | 2yrs